vidarabine has been researched along with Aplasia Pure Red Cell in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hale, G; Kussman, A; Oshrine, B; Petrovic, A; Shyr, D | 1 |
| Banov, L; Calvillo, M; Dufour, C; Fioredda, F; Fischer, A; Gallicola, F; Miano, M; Micalizzi, C; Molinari, AC; Montobbio, G; Parasole, R; Petruzziello, F; Poggi, V; Svahn, J | 1 |
| Hirano, T; Tsuji, T; Tuda, H; Yamasaki, H | 1 |
| Cervigón, I; Palomo, A; Solano, F; Torres-Iglesias, LM; Zapata, AM | 1 |
| Fujiwara, T; Harigae, H; Ishizawa, K; Kameoka, J; Minegishi, M; Miyamura, K; Sasaki, T; Tomiya, Y; Tsuchiya, S; Yamada, M | 1 |
| Au, WY; Chim, CS; Kwong, YL; Lam, CC; Pang, AW | 1 |
| Cho, HS; Kim, CC; Kim, SY; Kim, Y; Lee, JW; Lee, S; Lee, SM; Min, CK; Min, WS; Woo, HY | 1 |
| Borthakur, G; Cortes, JE; Giles, FJ; Kantarjian, HM; Keating, MJ; Lerner, S; O'Brien, S; Thomas, DA; Wierda, WG | 1 |
| Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
| He, GS; Jin, ZM; Miao, M; Sun, AN; Wang, XL; Wu, DP; Zhang, X | 1 |
| Leporrier, M; Reman, O; Troussard, X | 1 |
| Clauvel, JP; Jaccard, A; Oksenhendler, E | 1 |
| Antich Rojas, J; Balaguer, H; Cladera, A | 1 |
| Berrebi, A; Klepfish, A; Shimoni, A; Shtalrid, M; Shvidel, L; Sigler, E | 1 |
| Catovsky, D; Ribeiro, I; Tsatalas, C | 1 |
| Grau, E; Pastor, E; Real, E; Sandra, S | 1 |
| Ahn, J; Chi, H; Kim, W; Lee, J; Lee, K; Park, C | 1 |
| Egerer, G; Ho, AD; Sauerland, K | 1 |
| Bladé, J; Cervantes, F; Marín, P; Montserrat, E; Rozman, C; Rozman, M | 1 |
3 review(s) available for vidarabine and Aplasia Pure Red Cell
| Article | Year |
|---|---|
[Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
Topics: Aged; Antineoplastic Agents; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Red-Cell Aplasia, Pure; Treatment Outcome; Vidarabine | 2015 |
[Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Cyclophosphamide; Diagnosis, Differential; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Middle Aged; Mitoxantrone; Palate, Soft; Red-Cell Aplasia, Pure; Rituximab; Vidarabine | 2011 |
[Treatment with cyclosporin A of the anemia associated with chronic lymphatic leukemia].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclosporins; Erythropoiesis; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Red-Cell Aplasia, Pure; T-Lymphocytes, Regulatory; Thrombocytopenia; Vidarabine | 1990 |
16 other study(ies) available for vidarabine and Aplasia Pure Red Cell
| Article | Year |
|---|---|
Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prognosis; Red-Cell Aplasia, Pure; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2019 |
Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Resistance; Humans; Infant; Male; Red-Cell Aplasia, Pure; Sirolimus; Splenectomy; Treatment Outcome; Vidarabine | 2014 |
Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia.
Topics: ABO Blood-Group System; Adolescent; Blood Group Incompatibility; Cyclophosphamide; Graft Survival; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutrophils; Red-Cell Aplasia, Pure; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2004 |
Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Antineoplastic Agents; Cyclophosphamide; Cyclosporine; Dexamethasone; Drug Resistance, Neoplasm; Humans; Leukemia, T-Cell; Male; Mitoxantrone; Prednisolone; Red-Cell Aplasia, Pure; Remission Induction; Vidarabine | 2005 |
Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Bone Marrow Transplantation; Erythropoietin; Female; Humans; Leukocyte Transfusion; Medical Errors; Red-Cell Aplasia, Pure; Rituximab; Transplantation, Homologous; Vidarabine | 2006 |
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prospective Studies; Red-Cell Aplasia, Pure; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine | 2007 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Red-Cell Aplasia, Pure; Vidarabine | 2008 |
Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Red-Cell Aplasia, Pure; Vidarabine | 1993 |
Cytopenia and fludarabine.
Topics: Adult; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Red-Cell Aplasia, Pure; Vidarabine | 1993 |
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine | 1997 |
Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
Topics: Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Cyclosporine; Erythropoietin; Hemoglobins; Humans; Immunoglobulins, Intravenous; Immunophenotyping; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine | 1999 |
Treatment of red cell aplasia in CLL with fludarabine.
Topics: Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Red-Cell Aplasia, Pure; Vidarabine | 1999 |
Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
Topics: Humans; Immunosuppressive Agents; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Red-Cell Aplasia, Pure; Vidarabine | 1999 |
A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment.
Topics: Female; Humans; Immunosuppressive Agents; Middle Aged; Red-Cell Aplasia, Pure; Vidarabine | 2001 |
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Pancytopenia; Prednisone; Red-Cell Aplasia, Pure; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2001 |